Mengxue Yu

781 total citations
28 papers, 511 citations indexed

About

Mengxue Yu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Mengxue Yu has authored 28 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Mengxue Yu's work include Epigenetics and DNA Methylation (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mengxue Yu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mengxue Yu collaborates with scholars based in China, Japan and United States. Mengxue Yu's co-authors include Lingao Ju, Yu Xiao, Kaiyu Qian, Xinghuan Wang, Gang Wang, Changyong Li, Fenfang Zhou, Lijia Zhang, Hongli Shan and Haihai Liang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and Hypertension.

In The Last Decade

Mengxue Yu

26 papers receiving 507 citations

Peers

Mengxue Yu

ONCOL

PRM

IMMUN

Didem Taştekin Türkiye

Xianqiu Wu China

Qifei Zou China

Gaël S. Roth France

Mingbo Cao China

Snahlata Singh India

Suhua Xia China

Weihao Lin China

Soki Hibino Japan

Masataka Amisaki Japan

Didem Taştekin Türkiye

Mengxue Yu

185 ×0.7

115 ×0.9

197 ×1.7

ONCOL

87 ×0.8

PRM

61 ×0.7

IMMUN

Citations per year, relative to Mengxue Yu Mengxue Yu (= 1×) peers Didem Taştekin

Countries citing papers authored by Mengxue Yu

Since Specialization

Citations

This map shows the geographic impact of Mengxue Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxue Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxue Yu more than expected).

Fields of papers citing papers by Mengxue Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxue Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxue Yu. The network helps show where Mengxue Yu may publish in the future.

Co-authorship network of co-authors of Mengxue Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxue Yu. A scholar is included among the top collaborators of Mengxue Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxue Yu. Mengxue Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Xing, Mengxue Yu, Shihui Fu, et al.. (2025). Integrated Analyses to Identify the Roles of GPX1 in Frailty and Hypertension. Hypertension. 82(8). 1379–1391.

Xiao, Yu, Lingao Ju, Gang Wang, et al.. (2025). Elucidating the pathogenesis of bladder cancer through single-cell chromatin accessibility and DNA methylation analysis. Genes & Diseases. 12(5). 101578–101578.

Xiao, Yu, Wan Jin, Lingao Ju, et al.. (2024). Tracking single-cell evolution using clock-like chromatin accessibility loci. Nature Biotechnology. 43(5). 784–798. 13 indexed citations

Xiao, Yu, Lingao Ju, Jin Wan, et al.. (2024). Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis. Clinical and Translational Medicine. 15(1). e70153–e70153. 1 indexed citations

Li, Zhilong, Kaiyu Qian, Lingao Ju, et al.. (2024). Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics. The Pharmacogenomics Journal. 24(5). 24–24. 4 indexed citations

Ni, Ming, Mengxue Yu, Yishuang Sun, et al.. (2023). Targeting Notch1-YAP Circuit Reprograms Macrophage Polarization and Alleviates Acute Liver Injury in Mice. Cellular and Molecular Gastroenterology and Hepatology. 15(5). 1085–1104. 37 indexed citations

Yu, Mengxue, Kaiyu Qian, Gang Wang, et al.. (2023). Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma. Frontiers in Oncology. 13. 1114461–1114461. 11 indexed citations

Wang, Gang, Wan Jin, Lingao Ju, et al.. (2023). Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges. SHILAP Revista de lepidopterología. 3(1). 13 indexed citations

Deng, Zhao, Wei Liu, Fenfang Zhou, et al.. (2023). Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis. Cell Death and Disease. 14(4). 246–246. 23 indexed citations

10.

Deng, Zhao, Mengxue Yu, Fenfang Zhou, et al.. (2023). Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways. Cell Death Discovery. 9(1). 214–214. 12 indexed citations

11.

Yu, Mengxue, Min Zhou, Jiahui Li, et al.. (2022). Notch-activated mesenchymal stromal/stem cells enhance the protective effect against acetaminophen-induced acute liver injury by activating AMPK/SIRT1 pathway. Stem Cell Research & Therapy. 13(1). 318–318. 18 indexed citations

12.

Xu, Huimin, Lingao Ju, Yaoyi Xiong, et al.. (2021). E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death and Disease. 12(3). 239–239. 41 indexed citations

13.

Chen, Siming, Mengxue Yu, Lingao Ju, et al.. (2021). The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation. Cancer Cell International. 21(1). 119–119. 15 indexed citations

14.

Ge, Hui Ming, et al.. (2021). How to Enhance the Future of Urban Environments Through Smart Sustainable Urban Infrastructures?. SHILAP Revista de lepidopterología. 3 indexed citations

15.

Ju, Lingao, Fenfang Zhou, Mengxue Yu, et al.. (2021). The inhibitory effect of melatonin on human prostate cancer. Cell Communication and Signaling. 19(1). 34–34. 26 indexed citations

16.

Liang, Haihai, Mengxue Yu, Rui Yang, et al.. (2019). A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer. Molecular Therapy — Oncolytics. 16. 53–62. 37 indexed citations

17.

Darling, Gail, Heidi Schmidt, Mengxue Yu, et al.. (2018). MA20.06 Lung Cancer Screening Pilot for People at High Risk: Early Results on Cancer Detection and Staging. Journal of Thoracic Oncology. 13(10). S427–S427. 1 indexed citations

18.

Zhu, Junhao, Mengxue Yu, Pengfei Kong, et al.. (2018). Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model. Diagnostic and Interventional Imaging. 99(3). 135–142. 44 indexed citations

19.

Kong, Pengfei, L. Chen, Xiaohua Shi, et al.. (2018). Microwave ablation combined with doxorubicin enhances cell death via promoting reactive oxygen species generation in breast cancer cells. Diagnostic and Interventional Imaging. 99(12). 783–791. 5 indexed citations

20.

Qu, Mengmeng, Yuan Xu, Dan Liu, et al.. (2017). Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Immune-Mediated Liver Injury and Compromise Virus Control During Acute Hepatitis B Virus Infection in Mice. Stem Cells and Development. 26(11). 818–827. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact